118 related articles for article (PubMed ID: 15329251)
1. [Fluorodeoxyglucose-positron emission tomography in carcinoma of the esophagogastric junction].
Wang T; Sun YE; Chu XY; Tian JH; Liu Y
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):651-3. PubMed ID: 15329251
[TBL] [Abstract][Full Text] [Related]
2. The influence of (18)flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma.
Smith JW; Moreira J; Abood G; Aranha GV; Nagda S; Wagner RH; Shoup M
Am J Surg; 2009 Mar; 197(3):308-12. PubMed ID: 19245906
[TBL] [Abstract][Full Text] [Related]
3. [Fluorine-18 fluorodeoxyglucose-positron emission tomography imaging of carcinoma of cardia or fundus of stomach].
Wang T; Sun YE; Yu CH; Chang P; Yao SL; Tian JH; Wu X; Sun K; Yang B
Zhonghua Wai Ke Za Zhi; 2006 May; 44(10):661-4. PubMed ID: 16784672
[TBL] [Abstract][Full Text] [Related]
4. Using
Ma CL; Li XD; Sun XR; Zhao DB; Yuan YP; Yu YH
J Cancer Res Ther; 2018; 14(4):896-901. PubMed ID: 29970673
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for PET/CT with esophagogastric junction adenocarcinoma?
Fuster D; Mayoral M; Rubello D; Pineda E; Fernández-Esparrach G; Pagès M; Colletti PM; Pons F
Clin Nucl Med; 2015 Mar; 40(3):e201-7. PubMed ID: 25546207
[TBL] [Abstract][Full Text] [Related]
6. Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy.
Stagg J; Farukhi I; Lazaga F; Thompson C; Bradshaw L; Kaif M; Gould-Simon A; Schmidt R
Dig Dis Sci; 2015 May; 60(5):1335-42. PubMed ID: 25502332
[TBL] [Abstract][Full Text] [Related]
7. Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Ott K; Herrmann K; Lordick F; Wieder H; Weber WA; Becker K; Buck AK; Dobritz M; Fink U; Ulm K; Schuster T; Schwaiger M; Siewert JR; Krause BJ
Clin Cancer Res; 2008 Apr; 14(7):2012-8. PubMed ID: 18381939
[TBL] [Abstract][Full Text] [Related]
8. [Fluorine-18 fluorodeoxyglucose uptake in patients with primary lung cancer].
Wang T; Sun Y; Zhou N; Yao S; Wang R; Yin D
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):437-40. PubMed ID: 12139802
[TBL] [Abstract][Full Text] [Related]
9. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
10. The correlation between molecular pathological profiles and metabolic parameters of
Song J; Li Z; Chen P; Zhou N; Zhang Y; Yang Z; Wang X
Abdom Radiol (NY); 2020 Feb; 45(2):312-321. PubMed ID: 31111196
[TBL] [Abstract][Full Text] [Related]
11. [Fluorine-18 fluorodeoxyglucose uptake in patients with benign pulmonary nodules].
Yu CH; Wang T; Sun YE; Yao SL; Tian JH; Yin DY
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):90-2. PubMed ID: 16620664
[TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.
Ott K; Weber WA; Fink U; Helmberger H; Becker K; Stein HJ; Müller J; Schwaiger M; Siewert JR
World J Surg; 2003 Sep; 27(9):1035-9. PubMed ID: 12917760
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
14. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
[TBL] [Abstract][Full Text] [Related]
15. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
16. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
17. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
18. Solid splenic masses: evaluation with 18F-FDG PET/CT.
Metser U; Miller E; Kessler A; Lerman H; Lievshitz G; Oren R; Even-Sapir E
J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
[TBL] [Abstract][Full Text] [Related]
19. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between fluorodeoxyglucose uptake and vascular endothelial growth factor in early-stage nasophygeal carcinoma].
Fan YX; Shi WM; Li J; Yin JL; Yang CH; Gao MJ; Wu JZ; Liu QZ; Li KB
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2067-9. PubMed ID: 19861268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
